Though most may think of Magnetic Resonance Imaging, or MRI, as a tool to diagnose a broken bone or other orthopedic injuries, the technology has transformed screening for prostate cancer in recent years.

In 2019, Quincy Medical Group (QMG) announced the addition of a 3.0T MRI machine, the SIGNA™ Pioneer from GE Healthcare, which creates the highest-quality images currently available and decreases scan time for patients. For patients undergoing prostate cancer screening, the addition of the 3.0T MRI provides a much less invasive and more comfortable experience.

QMG Urologist Dr. Daniel Schneider said having this technology in Quincy provides local patients with advanced technology for identifying and diagnosing prostate cancer.

“Prostate MRI with the 3Tesla magnet has revolutionized the diagnosis and management of prostate cancer,” Dr. Schneider explained. “It gives me the ability to more accurately determine the presence or absence of concerning areas in the prostate in a non-invasive fashion.”

Before the use of MRI of the prostate became available, urologists had three tools available to evaluate /diagnose prostate cancer in men. These include the digital rectal exam, the PSA test (a blood test that measures the level of prostate-specific antigen), and transrectal ultrasound-guided biopsy.

Before joining QMG in 2016, Dr. Schneider used the 3.0T MRI machine for patients during his residency program. He is thrilled to have this level of technology available locally.

“When I was at Mayo Clinic, we routinely used this tool to help manage patients with elevated PSA and those patients with a history of negative biopsy. I am so excited to be able to offer this technology in Quincy, and it has given me an indispensable tool in the management of prostate cancer and elevated PSA,” he said.

The QMG Urology team includes Dr. Schneider, as well as Dr. Matthew Knudson and Physician Assistant Steven Rosen.

For more information on prostate cancer screening and urology services provided at QMG, call 217-222-6550, ext. 3421 or visit quincymedgroup.com.